223 completed, 183 unknown, 172 recruiting, 49 not yet recruiting. 365 Phase 2, 153 Phase 3, 113 Phase 1, 72 Not applicable, 19 Phase 4.
Follow Chemotherapy: new trials by email Literature Review of Chemotherapy trials Research Report on Chemotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome Shuganhuazhuo Formula, Targeted therapy, Immunotherapy - HCC - Hepatocellular Carcinoma, Chinese Herbal Medicine | Phase 2 | Not yet recruiting | Xiang-Qian | 120 | 2027-09-01 | 2026-08-27 |
| Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas NeuroBlate® Laser Ablation Laser Interstitial Thermal Therapy, Cemiplimab, Chemotherapy - Glioblastoma, Glioblastoma, IDH-wildtype | Phase 2 | Not yet recruiting | Washington University School of Medicine | 99 | 2026-11-30 | 2026-10-20 |
| SPGL008 in Combination With SSGJ-706 ± Chemotherapy for Advanced Non-small Cell Lung Cancer SSGJ-706, SPGL008, Chemotherapy - Non Small Cell Lung Cancer | Phase 2 | Not yet recruiting | Shenyang Sunshine Pharmaceutical Co., LTD. | 220 | 2026-11-01 | 2026-10-15 |
| Primary Radiotherapy In MEtastatic Lung Cancer Radiotherapy followed by chemotherapy, Standard of Care (SOC) - Carcinoma, Non-Small-Cell Lung (NSCLC) | Phase 3 | Recruiting | Trans Tasman Radiation Oncology Group | 420 | 2026-10-30 | 2026-10-23 |
| Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally Advanced Colon Cancer With pMMR/MSS short-course radiotherapy, Serplulimab, CapOx(Capecitabine+ Oxaliplatin) - Locally Advanced Colon Cancer, pMMR | Phase 3 | Not yet recruiting | Fudan University | 480 | 2026-10-15 | 2026-10-16 |
| A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment Chemotherapy, Immunotherapy, Intensity-Modulated Radiation Therapy - Lung Non-Small Cell Carcinoma | Phase 2 | Recruiting | Alliance for Clinical Trials in Oncology | 164 | 2026-10-14 | 2026-10-19 |
| [18F]-AraG PET Imaging in LA HNSCC [18F]-AraG radiotracer, Chemotherapy, Radiotherapy - Head and Neck Squamous Cell Carcinoma (HNSCC), Locally Advanced Head and Neck Squamous Cell Carcinoma | Early Phase 1 | Not yet recruiting | Indiana University | 5 | 2026-09-01 | 2026-07-22 |
| Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer With KRAS G12D Mutation DN022150, Chemotherapy - Pancreatic Cancer | Phase 3 | Not yet recruiting | Jiangxi Kvvit Pharmaceutical Co., Ltd. | 360 | 2026-09-01 | 2026-07-08 |
| Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer Acupuncture, sham acupuncture - Lung Cancer (NSCLC), Immune Checkpoint Blockade | Not applicable | Recruiting | West China Hospital | 82 | 2026-08-31 | 2026-09-02 |
| Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer Adebrelimab, Thymalfasin, Chemotherapy - Esophageal Cancer | Phase 2 | Not yet recruiting | The Affiliated Hospital of Putian University | 31 | 2026-08-30 | 2026-08-21 |
| Pemigatinib Plus PD-1 Inhibitor With or Without Chemotherapy in FGFR2 Fusion/Rearrangement-Positive Cholangiocarcinoma Pemigatinb, PD-1 inhibitors, Chemotherapy - Biliary Tract Cancer (BTC) | Phase 2 | Recruiting | Haitao Zhao, MD | 154 | 2026-08-20 | 2026-08-26 |
| Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial Anastrozole, Biospecimen Collection, Bone Scan - Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Phase 3 | Recruiting | National Cancer Institute (NCI) | 1978 | 2026-08-10 | 2026-10-26 |
| TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: A Multicenter, Single-arm Prospective Clinical Study. TACE combined with thermal ablation, Targeted Therapy, Immunotherapy - Gastric Cancer With Liver Metastases | Phase 2 | Not yet recruiting | Shandong Provincial Hospital | 40 | 2026-08-01 | 2026-05-22 |
| Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer Ubamatamab, Chemotherapy, Bevacizumab - Ovarian Cancer | Phase 1 / Phase 2 | Not yet recruiting | ARCAGY/ GINECO GROUP | 43 | 2026-08-01 | 2026-07-10 |
| Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer PF-08634404, Chemotherapy - Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ) | Phase 2 | Recruiting | Pfizer | 40 | 2026-07-02 | 2026-10-09 |
| Immunotherapy Combined With Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer Carbon ion external beam radiotherapy plus 3 courses of three-dimensional brachytherapy. - Uterine Cervical Neoplasms | Not applicable | Recruiting | Zhejiang Cancer Hospital | 30 | 2026-07-01 | 2026-07-14 |
| Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer Camrelizumab, Famitinib Malate, Chemotherapy - Cervical Cancer | Phase 2 | Not yet recruiting | Hunan Cancer Hospital | 54 | 2026-06-30 | 2026-06-04 |
| ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer HPV ctDNA Response based radiation, Chemotherapy, Retifanlimab - Anal Cancer, HPV-Related Carcinoma | Phase 2 | Recruiting | Jennifer Dorth | 33 | 2026-06-19 | 2026-08-14 |
| Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM SBRT, PD-1 Antibody, H101 - CRC, Liver Metastasis Colon Cancer | Phase 2 | Not yet recruiting | Jun Huang | 114 | 2026-06-01 | 2026-04-28 |
| Propranolol Hydrochloride Combined With Toripalimab and Platinum-based Chemotherapy in Resectable Non-Small Cell Lung Cancer Propranolol Hydrochloride, Toripalimab, Chemotherapy - Resectable Non-Small-Cell Lung Cancer | Phase 1 | Recruiting | Second Xiangya Hospital of Central South University | 9 | 2026-06-01 | 2026-10-21 |
Showing 20 of 759. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (94) · Breast Neoplasms (77) · Colorectal Neoplasms (53) · Lung Neoplasms (42) · Neoplasms (38) · Pancreatic Neoplasms (36) · Ovarian Neoplasms (34) · Stomach Neoplasms (33) · Neoplasm Metastasis (31) · Esophageal Neoplasms (28) · Esophageal Squamous Cell Carcinoma (24) · Rectal Neoplasms (24) · Squamous Cell Carcinoma of Head and Neck (24) · Leukemia, Myeloid, Acute (22) · Glioblastoma (19)
Sun Yat-sen University (23) · Fudan University (19) · Peking Union Medical College Hospital (16) · Hoffmann-La Roche (15) · M.D. Anderson Cancer Center (15) · National Cancer Institute (NCI) (13) · Pfizer (10) · Ruijin Hospital (8) · Shanghai Chest Hospital (8) · Second Affiliated Hospital, Zhejiang University, School of Medicine (7) · Tianjin Medical University Cancer Institute and Hospital (7) · UNICANCER (7) · Zhejiang Cancer Hospital (7) · Alliance for Clinical Trials in Oncology (6) · H. Lee Moffitt Cancer Center and Research Institute (6)
China (279) · United States (229) · France (68) · Italy (59) · Spain (51) · Germany (48) · South Korea (36) · United Kingdom (33) · Canada (32) · Belgium (31) · Netherlands (28) · Australia (27) · Taiwan (25) · Switzerland (24) · Austria (20)
You Lu, MD (4) · Birendra K Sah, PH D (3) · Chen Li, PH D (3) · Hongmeng Yu, MD,PHD (3) · Paul Schwarzenberger, MD (3) · Zhenggang Zhu, PH D (3) · Brigette Ma, MD, FRCP (2) · Chong Zhao, MD PhD (2) · Dennis Shrieve, MD (2)
PMID 30062662, PMID 39368878, PMID 40288679, PMID 10655437, PMID 10813118, PMID 11560968, PMID 11870157, PMID 11937316, PMID 12177103, PMID 12434281, PMID 12525193, PMID 14506149, PMID 14645425, PMID 14645636, PMID 15128893, PMID 15131031, PMID 15383798, PMID 15496622, PMID 15534360, PMID 15812833, PMID 15936546, PMID 15961764, PMID 16011702, PMID 16078267, PMID 16135463, PMID 16265674, PMID 16510333, PMID 16598416, PMID 16626792, PMID 16645718, PMID 17175450, PMID 1729745, PMID 17404369, PMID 17515386, PMID 17544337, PMID 17647306, PMID 17882490, PMID 17896138, PMID 17896890, PMID 17909941, PMID 18217208, PMID 18248979, PMID 18577561, PMID 18640307, PMID 18650162, PMID 18784962, PMID 18955565, PMID 18990510, PMID 19029956, PMID 19147777
2017 (7), 2023 (6), 2016 (5), 2025 (5), 2018 (4), 2014 (3), P30CA015704 (3), P30CA016672 (3), U10CA180820 (3), 2005 (2), 2009 (2), 2015 (2), P30CA006973 (2), P30CA033572 (2), P30CA036727 (2)